Bruce  D Greenwald
 

Bruce D Greenwald M.D.

Academic Title: Professor
Primary Appointment: Medicine
Additional Title(s): Fellowship Program Director
BGREENWA@medicine.umaryland.edu
Location: UMMC, Room N3W62
Phone: (410) 328-8731
Fax: (410) 328-8315

Research Interests

Dr. Greenwald's clinical and research interests involve malignant and pre-malignant diseases of the esophagus. These include esophageal carcinoma, Barrett’s esophagus and esophageal squamous dysplasia. Specific research interests include staging methods for esophageal cancer and endoscopic ablation therapies for Barrett’s esophagus and esophageal cancer.

Publications

Suntharalingam M, Haas ML, Sonett JR, Doyle A, Hausner PF, Schuetz J, Greenwald B, Krasna MJ. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Cancer J 2001; 7:509-515

Jiao X, Sonett J, Gamliel Z, Doyle A, Schuetz J, Greenwald B, Suntharalingam M, Krasna MJ. Trimodality treatment versus surgery alone for esophageal cancer. A stratified analysis with minimally invasive pretreatment staging. J Cardiovasc Surg (Torino). 2002; 43(4):531 7.

Krasna MJ, Jiao X, Mao YS, Sonett J, Gamliel Z, Kwong K, Burrows W, Flowers JL, Greenwald B, White C.Thoracoscopy/laparoscopy in the staging of esophageal cancer: Maryland experience. Surg Laparosc Endosc Percutan Tech. 2002;12(4):213 8.

Li XA, Chibani O, Greenwald B, Suntharalingam M. Radiotherapy dose perturbation of metallic esophageal stents. Int J Radiat Oncol Biol Phys. 2002 ;54(4):1276 85.

Sobel JM, Lai R, Mallery S, Levy MJ, Wiersema MJ, Greenwald BD, Gunaratnam NT. The utility of EUS-guided FNA in the diagnosis of metastatic breast cancer to the esophagus and the mediastinum. Gastrointest Endosc. 2005: 61(3):416-20.

Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 2005 9;24(25):4138-48.




Faculty members: Click here to update your contact information and create a profile.


This site will work and look much better in a modern web browser, such as Internet Explorer 6, Firefox, or Safari 1.2 (Mac)
© University of Maryland School of Medicine